Solving VC’s ESG Puzzle, by @gabekleinman 

The reason VC’s are gaining ESG altitude is simple: institutional investors and family offices are now leaning in. Origen: Solving VC’s ESG Puzzle. Upstream investment strategy remains… | by Gabe Kleinman | May, 2021 | World Positive Environmental, Social, and Governance (“ESG”) standards are having a moment with climate change (and climate risk), broad socioeconomic [...]

“Betting on Biotech” report by @pitchbook

Cultivating an understanding of the VC investment landscape of US-based biotech & pharma startups. Origin: PitchBook Analyst Note: Betting on Biotech Key takeaways: Over the last few decades, the biotechnology & pharmaceuticals (biotech & pharma) industry has seen a shift from drug development through internal R&D efforts at large-cap public incumbents to an M&A-based model. The drug [...]

11 Lessons From Venture Capitalist Fred Wilson by @CBInsights Research

–Early revenue growth isn’t always a positive —instead, focus on market fit— –Growth isn’t always worth it Origen: 11 Lessons From Venture Capitalist Fred Wilson - CB Insights Research Product development Keep your vision simple at the beginning Early revenue growth isn’t always a positive — instead, focus on market fit “A hard charging sales [...]

Go to Top